Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-115916)

Filing Details

Accession Number:: 0001104659-21-115916
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-15 16:03:13
Reporting Period:: 2021-09-15

Accepted Time:: 2021-09-15 16:03:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1644963	Avenue Therapeutics Inc.	ATXI	Pharmaceutical Preparations (2834)	474113275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1715291	Walter Joseph Vazzano	1140 Avenue Of The Americas, Floor 9 New York NY 10036	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-09-15	7,160	$1.62	65,252	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

On September 15, 2021, a total of 7,160 shares were sold by the Company at a weighted average sales price of $1.62 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.